252
Participants
Start Date
October 12, 2012
Primary Completion Date
October 9, 2014
Study Completion Date
June 17, 2015
Romosozumab
Administered by subcutaneous injection
Placebo
Administered by subcutaneous injection
Research Site, Anjyo-shi
Research Site, Fukuoka
Research Site, Kitakyushu-shi
Research Site, Yanagawa-shi
Research Site, Mizunami-shi
Research Site, Sapporo
Research Site, Sapporo
Research Site, Morioka
Research Site, Yokohama
Research Site, Yokohama
Research Site, Kyoto
Research Site, Sendai
Research Site, Sendai
Research Site, Saito-shi
Research Site, Matsumoto-shi
Research Site, Ueda-shi
Research Site, Ueda-shi
Research Site, Osaka
Research Site, Takatsuki-shi
Research Site, Kita-adachi-gun
Research Site, Hachioji-shi
Research Site, Kiyose-shi
Research Site, Minato-ku
Research Site, Ōta-ku
Research Site, Shinagawa-ku
Research Site, Suginami-ku
Research Site, Toshima-ku
Lead Sponsor
Amgen
INDUSTRY